Abstract:Background: Autophagy, one of protein degradation system, contributes to maintain cellular homeostasis.Dysfunction of autophagy is associated with the development and progression of various liver diseases including nonalcoholic fatty liver disease (NAFLD) and hepatic cancer.Nuclear matrix protein (NMP) has been demonstrated to participate in many cellular functions.Changes in nuclear matrix structures result in alteration of DNA topology and the interaction of various genes with the matrix.The search for specific NMP modifications in tumors is available for diagnostic or prognostic markers for cancer.Here, we performed proteomic analysis of NMP to identify the novel autophagy-related diagnostic biomarker for NAFLD.Method: Insoluble nuclear protein fraction was extracted from the liver of Atg7 F/ F (wild type), Atg7 F/F :alb-Cre (Atg7 KO), C57BL/6J (control) and KKA y mice (NAFLD model).Proteins were separated with two-dimensional electrophoresis and visualized by silver stain.Protein spots were identified by mass spectrometry.Localization of identified proteins in a cell was verified by immunofluorescence using laser-scanning confocal microscope.Western blot analysis was performed to detect NMPs in serum.Localization of importin a4 and b1 in hepatocytes transfected with GFP-importin a4 or b1 plasmid was evaluated by laserscanning confocal microscope.Result: Twelve nuclear insoluble proteins up-regulated in both autophagy-deficient and NAFLD mice liver were identified.14-3-3 z, importin a4 and b1 were expressed in NMP and localized to nucleus in hepatocytes from both Atg7 KO and KKA y mice, in wild type and control mice, these NMPs were distributed into cytoplasm.14-3-3z, importin a4 and b1 were detectable in serum, and expressed in serum from autophagy-deficient mice and NAFLD model higher than wild type and control mice.Treatment with mTOR inhibitor rapamycin down-regulated the accumulation of 14-3-3 z in NMPs from KKA y mice.Importin a4 and b1 was translocated into nucleus by incubation with tunicamycin or H 2 O 2 for 12 hours.Conclusion: These results suggest that loss of autophagy alters expression of several nuclear proteins.Three autophagy-related NMP 14-3-3z, importin a4 and b1 were up-regulated in NAFLD model and detected in serum.Accumulation of 14-3-3z in NMPs is suggested to be associated with activation of mTOR.Increases in importin a4 and b1 in these NMPs indicate ER stress and oxidative stress.Evaluation of serum level of these NMPs may be useful tool for diagnosis of NAFLD with autophagy dysfunction.

FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice

Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation

FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity.

Hepatic CPT1A Facilitates Liver–Adipose Cross Talk via Induction of FGF21 in Mice

High-fat Diet and Palmitate Inhibits FNDC5 Expression Via AMPK-Zfp57 Pathway in Mouse Muscle Cells.

Betaine Alleviates Nonalcoholic Fatty Liver Disease (NAFLD) Via a Manner Involving BHMT/FTO/m6A/ PGC1α Signaling.

FNDC5 Overexpression and Irisin Ameliorate Glucose/lipid Metabolic Derangements and Enhance Lipolysis in Obesity

Fatty Acids Promote Fatty Liver Disease Via the Dysregulation of 3-Mercaptopyruvate Sulfurtransferase/hydrogen Sulfide Pathway.

Sa1666 IGFBP1 Decreases Free Fatty Acid-Induced Hepatocyte Steatosis through Phosphorylation of FAK

Functional Proteomic Analysis of Nonalcoholic Fatty Liver Disease in Rat Models: Enoyl-coenzyme a Hydratase Down-Regulation Exacerbates Hepatic Steatosis

Dysfunction of Autophagy in High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease

Systemic Overexpression of GDF5 in Adipocytes but Not Hepatocytes Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver in Mice

Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease

FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease

1599-P: Regulation of Mitochondrial Dynamics Ameliorates Hepatic Steatosis through TFEB Activation

FNDC5 Attenuates Oxidative Stress and NLRP3 Inflammasome Activation in Vascular Smooth Muscle Cells Via Activating the AMPK-SIRT1 Signal Pathway

Hepatocyte-secreted FAM3D Ameliorates Hepatic Steatosis by Activating FPR1-hnRNP U-GR-SCAD Pathway to Enhance Lipid Oxidation

Fndc5 loss-of-function attenuates exercise-induced browning of white adipose tissue in mice

FNDC5 Promotes Adipogenic Differentiation of Primary Preadipocytes in Mashen Pigs

Transcription factor EB inhibits non-alcoholic fatty liver disease through fibroblast growth factor 21

FNDC5 Alleviates Oxidative Stress and Cardiomyocyte Apoptosis in Doxorubicin-Induced Cardiotoxicity Via Activating AKT